The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Efficacy and tolerability of trabectedin in heavily pretreated soft tissue sarcomas (STS).
Teresa Alonso
No relevant relationships to disclose
Pablo Gajate
No relevant relationships to disclose
Antonio Casado
No relevant relationships to disclose
Eduardo Raul Segura Gonzalez
No relevant relationships to disclose
Luis Ortega
No relevant relationships to disclose
Juan Luis Cebrian
No relevant relationships to disclose
Pablo Talavera
No relevant relationships to disclose
Jon Zugazagoitia
No relevant relationships to disclose
Daniel Acosta
No relevant relationships to disclose
Eduardo Diaz-Rubio
No relevant relationships to disclose